Scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream.

Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...

This has several benefits and advantages, but also means that creating an exam timetable can be a very complex process. Work on the timetable starts 3-4 months before the exam period and involves ...

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug ...

Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to ...

If you have psoriasis on your arms and are insecure about it, you may experience challenges to both your physical and mental well-being. Therapy can help you cope with the impacts of psoriasis. Hiding ...

Certain psoriasis treatments can cause liver toxicity ... To diagnose liver disease, your doctor will perform a physical exam and run a few tests. According to the American Liver Foundation ...

CBSE Class 12 Physical Education Exam Tips 2024: CBSE Class 12 Physical Education Exam is scheduled for March 12, 2024 (Tuesday). With lakhs of students opting for Physical Education as an ...

An eye doctor will do a physical exam of your child's eyes, along with vision screenings. They'll use eye chart tests, pictures, letters, or the "tumbling E game." This game can check how well ...

The Central Board of Secondary Education (CBSE) on February 25 held the Social Science exam for Class 10. The paper was held for 80 marks and students were allotted three hours to complete the paper.

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a pair of phase 3 trials. The Protagonist Therapeutics-partnered IL-23 ...